For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary.
They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose, even if it takes more time.
The patient featured in the article has survived lung cancer for 15 years. Seems a little long to feel badly when it’s possible for newer types of therapies to use lower doses that are just as effective.